Basic good manufacturing practices (GMP), special conditions and inspection processes in the Covid19 (SARS-CoV-2) pandemic

The COVID-19 pandemic has severely impacted the world economy, businesses and global health. Exceptional situations are evident in the food, cosmetics and pharmaceutical production in the supply chain, where many businesses have been shut down completely following government restrictions. In the pandemic process, it has become much more important to ensure hygienic products and employee safety and to deliver quality and healthy products to the consumer. In extraordinary conditions, it is necessary to provide additional contributions to the principles of good manufacturing practices. With the additional measures to be taken during the epidemic period, a healthy and safe operation can be brought to production. In addition, the assurance system can continue to function despite restrictions and failing audits. In addition to the updated guides, the development of roadmaps specific to the epidemic period for production may provide the advantage of being ready for problems.